Generic Name


Therapeutic Category



Albendazole 400mg Tablets

Albendazole 400mg/10ml Suspension



     WORMSTAT TAB  Each tablet contains:
    Albendazole BP                        400mg
    Light pink coloured, oblong uncoated tablet with breakline on one side
    WORMSTAT SUSPENSION: Each10 ml contains:
    Albendazole USP                     400mg
    Off white colored flavoured suspension filled in amber coloured glass bottle and sealed with ROPP cap.


    Food Interaction: Food significantly increases the absorption of albendazole.

    Administration: Should be taken with food.

    Pregnancy: Category C

    Storage: Store tablets between 20-25°C

    Missed dose: Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose


    Pharmacotherapeutic Group:Antihelmentic Drug

     Pharmacodynamic Properties:Albendazole sulfoxide (active metabolite), causes selective degeneration of cytoplasmic microtubules in intestinal and tegmental cells of intestinal helminths and larvae; glycogen is depleted, glucose uptake and cholinesterase secretion are impaired and desecretory substances accumulate intracellulary. ATP production decreases, causing energy depletion, immobilisation and worm death.

     Pharmacokinetic Properties:

    Absorption: Poorly absorbed from the GI tract. Absorption may be enhanced by a fatty meal.Time to peak plasma concentration: 2-5 hr.

    Distribution: Widely distributed throughout the body including the bile and Cerebrospinal Fluid (CSF). Plasma protein binding: Approx. 70%

    Metabolism: Undergoes extensive hepatic first-pass metabolism; converted to albendazole

    Excretion: Mainly via the bile, and small amounts in urine. Plasma half-life: Approximately 8.5 hr.


    Hydatid disease, neurocysticercosis, ascariasis, hookworm infections, filariasis, cutaneous larva migrans.


    Enterobiaisis, Ascariasis, Hookworm infections:Adult: 400 mg as a single dose.Child: ≥2 yr: 400 mg as a single dose; 1-2 yr: 200 mg as a single dose. Echinococcosis/ Hydatid disease:400mg BD for 4 weeks, repeat after 2 weeks if needed up to three courses


    Headache, increased intracranial pressure, dizziness, fever, vertigo, meningeal signs, alopecia, abdominal pain, nausea and vomiting, hypersensitivity reactions including rash and urticaria


    Patient with retinal lesions. Patient treated for neurocysticercosis should receive appropriate steroid and anticonvulsant therapy as required. Pregnancy and lactation


    Increased serum concentrations with dexamethasone, praziquintel and cimetidine. Decreased serum concentrations with aminoquinolone (antimalarials), carbamazepine, phenobarbital and phenytoin. Plasma concentration of theophylline be monitered during and after treatment as albendazole induces cytochrome P4501A in human hepatoma cells.


    Patients with hypersensitivity to albendazole or its components; pregnant women



    WORMSTAT: Each box contains 20 Blister of 1 tablet per strip

    WORMSTAT SUSPENSION: Each bottle contains 10ml of suspension